Whitepaper: Estimating the Impact of COVID-19 on Healthcare Costs in 2020– Key Factors of the Cost Trajectory1 min read

Conventional wisdom holds that COVID-19 is increasing costs for healthcare payers due to an influx of patients in need of testing and treatment. While these costs are significant, a Milliman analysis reveals that the deferred and elimination of care is a far more impactful driver of costs. Milliman projects a net reduction in medical costs for healthcare payers by at least $75 billion and as much as $575 billion if the deferral and elimination of care continues through the end of 2020. Download the Milliman whitepaper. 

Leave a Reply

Your email address will not be published.

This Content Is Made Possible by our Generous Research Associates:

Do you need an answer immediately?

Check out our FAQ page!

Skip to toolbar